Lexicon Pharmaceuticals
LXRX
LXRX
122 hedge funds and large institutions have $243M invested in Lexicon Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 31 increasing their positions, 36 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 126 → 122 (-4)
13% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 32
14% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 36
Holders
122
Holding in Top 10
1
Calls
$805K
Puts
$145K
Top Buyers
| 1 | +$2.33M | |
| 2 | +$1.94M | |
| 3 | +$1.31M | |
| 4 |
Millennium Management
New York
|
+$1.06M |
| 5 |
Jane Street
New York
|
+$521K |
Top Sellers
| 1 | -$4.31M | |
| 2 | -$2.36M | |
| 3 | -$1.16M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.1M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$850K |